First Header Logo Second Header Logo

Connection

Perry Shen to Thalidomide

This is a "connection" page, showing publications Perry Shen has written about Thalidomide.
Connection Strength

0.476
  1. Shen P, Thomas CR, Fenstermaker J, Aklilu M, McCoy TP, Levine EA. Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer. J Gastrointest Cancer. 2014 Sep; 45(3):268-75.
    View in: PubMed
    Score: 0.476
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.